MammaPrint(R) Approved for Reimbursement in Germany

IRVINE, Calif., Oct. 21, 2020 -- (Healthcare Sales & Marketing Network) -- Agendia Inc., a world leader in precision oncology for breast cancer, announced today that the Federal Joint Committee (G-BA) has approved MammaPrint® , Agendia's 70-Gene Breas... Diagnostics, Oncology, Reimbursement Agendia, MammaPrint, breast cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news